Location History:
- Laval, CA (2000)
- Lachine, CA (2002)
Company Filing History:
Years Active: 2000-2002
Title: Sylvie Desmarais: Innovator in Binding Assays
Introduction
Sylvie Desmarais is a prominent inventor based in Laval, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of binding assays for proteases and phosphatases. With a total of 3 patents, her work has important implications for medical research and drug discovery.
Latest Patents
Desmarais's latest patents include innovative ligands for phosphatase binding assays. These ligands are designed for use in binding assays that target proteases and phosphatases, incorporating cysteine in their binding sites. The unique feature of her assay is the use of a mutant form of the enzyme, which helps to eliminate interference from oxidizing and alkylating agents. This advancement allows for more accurate determination of the binding ability of new ligands compared to known enzyme inhibitors. Her work has applications in treating various diseases, including diabetes, cancer, and Alzheimer's disease.
Career Highlights
Sylvie Desmarais is currently employed at Merck Frosst Canada & Co., where she continues to advance her research in biochemistry. Her innovative approaches to binding assays have positioned her as a leader in her field.
Collaborations
Desmarais has collaborated with notable colleagues, including Richard W. Friesen and Robert J. Zamboni. These partnerships have further enhanced her research and contributed to the success of her projects.
Conclusion
Sylvie Desmarais is a trailblazer in the development of binding assays, with her work paving the way for advancements in medical research. Her contributions are vital for the discovery of new treatments for various diseases.